185 related articles for article (PubMed ID: 18053981)
1. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.
Qi C; Zou H; Zhang R; Zhao G; Jin M; Yu L
Eur J Pharmacol; 2008 Feb; 580(1-2):161-8. PubMed ID: 18053981
[TBL] [Abstract][Full Text] [Related]
2. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.
Wu J; Zou H; Strong JA; Yu J; Zhou X; Xie Q; Zhao G; Jin M; Yu L
Psychopharmacology (Berl); 2005 Jan; 177(3):256-63. PubMed ID: 15290006
[TBL] [Abstract][Full Text] [Related]
3. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
4. Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
de Oliveira RV; Dall'Igna OP; Tort AB; Schuh JF; Neto PF; Santos Gomes MW; Souza DO; Lara DR
Behav Pharmacol; 2005 Mar; 16(2):79-84. PubMed ID: 15767842
[TBL] [Abstract][Full Text] [Related]
5. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
Ranaldi R; Munn E; Neklesa T; Wise RA
Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
[TBL] [Abstract][Full Text] [Related]
6. Effect of GNTI, a kappa opioid receptor antagonist, on MK-801-induced hyperlocomotion and stereotypy in mice.
Qi CT; Zou H; Zhang CH; Xie QL; Jin ML; Yu L
Acta Pharmacol Sin; 2006 Nov; 27(11):1401-8. PubMed ID: 17049114
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical effects of very low dose MK-801.
Tang Y; Zou H; Strong JA; Cui Y; Xie Q; Zhao G; Jin M; Yu L
Eur J Pharmacol; 2006 May; 537(1-3):77-84. PubMed ID: 16626696
[TBL] [Abstract][Full Text] [Related]
8. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
Wedzony K; Czyrak A; Maćkowiak M; Fijał K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
[TBL] [Abstract][Full Text] [Related]
9. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice.
Jeon SJ; Kim E; Lee JS; Oh HK; Zhang J; Kwon Y; Jang DS; Ryu JH
Neuropharmacology; 2017 Nov; 126():168-178. PubMed ID: 28899728
[TBL] [Abstract][Full Text] [Related]
10. MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors.
Ho YJ; Chen KH; Tai MY; Tsai YF
Pharmacol Biochem Behav; 2004 Mar; 77(3):641-6. PubMed ID: 15006477
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit.
Gray L; McOmish CE; Scarr E; Dean B; Hannan AJ
Int J Neuropsychopharmacol; 2009 Aug; 12(7):917-28. PubMed ID: 19236734
[TBL] [Abstract][Full Text] [Related]
12. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
13. Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
Ninan I; Kulkarni SK
Eur J Pharmacol; 1999 Feb; 368(1):1-7. PubMed ID: 10096763
[TBL] [Abstract][Full Text] [Related]
14. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
Lapin IP; Rogawski MA
Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
[TBL] [Abstract][Full Text] [Related]
15. Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus).
Hoffman KL; Basurto E
Behav Brain Res; 2014 Sep; 271():203-11. PubMed ID: 24933188
[TBL] [Abstract][Full Text] [Related]
16. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
Uehara T; Sumiyoshi T; Seo T; Matsuoka T; Itoh H; Suzuki M; Kurachi M
Brain Res; 2010 Sep; 1352():223-30. PubMed ID: 20633540
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
[TBL] [Abstract][Full Text] [Related]
18. The effect of MK-801 and SCH23390 on the expression and sensitization of morphine-induced oral stereotypy.
Livezey RT; Pearce LB; Kornetsky C
Brain Res; 1995 Sep; 692(1-2):93-8. PubMed ID: 8548325
[TBL] [Abstract][Full Text] [Related]
19. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
[TBL] [Abstract][Full Text] [Related]
20. The effect of neonatal N-methyl-D-aspartate receptor blockade on exploratory and anxiety-like behaviors in adult BALB/c and C57BL/6 mice.
Akillioglu K; Binokay S; Kocahan S
Behav Brain Res; 2012 Jul; 233(1):157-61. PubMed ID: 22562039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
